Trial
NCT01478828
Pre-Prostatectomy Lovastatin on Prostate Cancer
UnknownTERMINATEDSAFETYConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Patrick C Walsh Prostate Cancer Research Fund
Condition
Prostate Cancer
Intervention
Lovastatin
Why stopped
The study was stopped due to an unanticipated serious adverse event.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-27